Investigators involved in toremifene studies call it a potentially safer antiestrogen.
D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000517:prevention & control; D003257:Consumer Product Safety; D004965:Estrogen Antagonists / Q000494:pharmacology*; D005260:Female; D006801:Humans; D012108:Research Personnel; D017312:Toremifene / Q000494:pharmacology*
D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D017312:Toremifene